Literature DB >> 15691273

Protection against acute porcine lung ischemia/reperfusion injury by systemic preconditioning via hind limb ischemia.

Thomas Waldow1, Konstantin Alexiou, Wolfgang Witt, Steffen Albrecht, Florian Wagner, Michael Knaut, Klaus Matschke.   

Abstract

Previous work on various organs and tissues has shown that ischemic preconditioning protects against reperfusion injury in these organs and also against secondary effects in the lung. In contrast, the purpose of this study was to investigate the effects of preconditioning in a remote organ (hind limb ischemia) on an ischemia/reperfusion (I/R) treatment of the lung itself. A porcine model of in situ left lung ischemia (90 min) and reperfusion (5 h) was used. Systemic preconditioning was induced by clamping the left common femoral artery (3 x 5 min). Lung injury was assessed in terms of pulmonary vascular resistance, pulmonary artery pressure, pulmonary venous and arterial pO(2), and tissue macrophage counts. The zymosan-stimulated release of reactive oxygen species (ROS) in whole blood was determined by a chemiluminometric procedure. Inflammatory cytokines (interleukin-1beta and interleukin-6) were measured in arterial plasma as indicators of a systemic inflammatory reaction. Preconditioning by hind limb ischemia completely prevented the I/R-induced functional impairment of the lung, the pulmonary hypertension and the reduced oxygenation capacity. The plasma levels of interleukin-1beta and the macrophage counts in preconditioned animals were reduced to control values, whereas the levels of interleukin-6 and the release of ROS were not affected by preconditioning. In conclusion, systemic preconditioning by repeated hind limb ischemia protects against acute I/R injury of the lung but not against all indices of reperfusion-associated systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691273     DOI: 10.1111/j.1432-2277.2004.00005.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  17 in total

1.  Harnessing the preconditioning phenomenon: does remote organ ischaemia provide the answer?

Authors:  A Burdess; D Newby
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 2.  [Myocardial preconditioning with volatile anesthetics. General anesthesia as protective intervention?].

Authors:  H Buchinger; U Grundmann; S Ziegeler
Journal:  Anaesthesist       Date:  2005-09       Impact factor: 1.041

3.  Response to letter by Dr. M. S. A. Mohamed (Antagonizing reactive oxygen species during lung perfusion).

Authors:  Shampa Chatterjee; Gary F Nieman; Jason D Christie; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-01       Impact factor: 5.464

4.  Remote ischaemic preconditioning of the lung: from bench to bedside-are we there yet?

Authors:  Nina C Weber; Coert J Zuurbier; Markus W Hollmann
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

5.  Effect of remote ischemic preconditioning on hepatic microcirculation and function in a rat model of hepatic ischemia reperfusion injury.

Authors:  Niteen Tapuria; Sameer P Junnarkar; Neelanjana Dutt; Mahmoud Abu-Amara; Barry Fuller; Alexander M Seifalian; Brian R Davidson
Journal:  HPB (Oxford)       Date:  2009-03       Impact factor: 3.647

6.  Mitochondria as the memory of preconditioning.

Authors:  Sarah Zerimech; Hung Nguyen; Selva Baltan
Journal:  Cond Med       Date:  2021-08-21

Review 7.  Biomarkers for ischemic preconditioning: finding the responders.

Authors:  Sebastian Koch; David Della-Morte; Kunjan R Dave; Ralph L Sacco; Miguel A Perez-Pinzon
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-19       Impact factor: 6.200

8.  Remote ischemic conditioning: from bench to bedside.

Authors:  Shiang Yong Lim; Derek John Hausenloy
Journal:  Front Physiol       Date:  2012-02-20       Impact factor: 4.566

9.  Endogenous Agmatine Induced by Ischemic Preconditioning Regulates Ischemic Tolerance Following Cerebral Ischemia.

Authors:  Jae Hwan Kim; Jae Young Kim; Jin Young Jung; Yong Woo Lee; Won Taek Lee; Seung Kon Huh; Jong Eun Lee
Journal:  Exp Neurobiol       Date:  2017-12-13       Impact factor: 3.261

10.  Pretreatment with Erythropoietin Attenuates Lung Ischemia/Reperfusion Injury via Toll-Like Receptor-4/Nuclear Factor-κB (TLR4/NF-κB) Pathway.

Authors:  Qian He; Xueshan Zhao; Siwei Bi; Yu Cao
Journal:  Med Sci Monit       Date:  2018-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.